African-Americans with colorectal cancer have poorer outcomes, lower survival rates

	Tweet

New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans.

Racial disparities previously have been demonstrated in numerous studies for a number of cancers, typically due to unequal access to care. As a result, the identification and elimination of these disparities has become a national public health priority.

“Colorectal cancer is the only gastrointestinal cancer that is routinely screened for and can be effectively treated, yet African-Americans still have a profoundly lower survival rate than Caucasians,” said Timothy L. Fitzgerald, MD, FACS, associate professor, department of surgery, division of surgical oncology, East Carolina University in Greenville, NC. “Our analysis suggests that these disparities may be attributable to a lack of access to or use of care. It is imperative that screening and treatment are delivered equally to all patients.”

East Carolina researchers used four years of population-based Medicare and Medicaid administrative claims merged with the Michigan Tumor Registry and identified data for 18,260 patients (≥66 years) with colorectal (n=13,001; 11.31 percent African-American), pancreatic (n=2,427; 14.38 percent African-American), gastric (n=1,739; 17.49 percent African-American) and esophageal (n=1,093; 13.50 percent African-American) cancer. Key data used in the analysis included likelihood of late-stage diagnosis, likelihood of surgical treatment after diagnosis, and survival.

In evaluating an unadjusted analyses, researchers discovered that African-American patients with colorectal cancer were more likely to present with metastatic disease (23.17 percent versus 14.75 percent Caucasians; p<0.05) and less likely to undergo operations (71.25 percent versus 79.05 percent; p<0.05), regardless of socioeconomic factors. This finding was the case even when the analysis was confined to patients with localized, surgically treatable diseases.

The median survival of African-Americans with colorectal cancer (39 months versus 56 months) and esophageal cancer (5 months versus 9 months) in the study was significantly less than that for Caucasians (p < 0.05). Survival was similarly poor for pancreatic and gastric cancer patients regardless of race.

In conducting a multivariate analysis, the research team found that African-American patients had a higher likelihood of dying from colorectal cancer than Caucasian patients did. However, this difference did not persist when adjustments were made for disease stage and presence or absence of a surgical procedure (hazard ratio = 1.15, 95% CI = 1.06 – 1.24). There was no association between survival and race for patients with esophagus, gastric or pancreatic cancer. Other variables of interest and statistical significance were median household income below $35,000, a dual eligibility insurance status and older age, all of which were negatively associated with colorectal cancer survival.

###

About the American College of Surgeons

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and to improve the care of the surgical patient. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 77,000 members and is the largest organization of surgeons in the world. For more information, visit http://www.facs.org.

Contact: Sally Garneski

312-202-5409
Weber Shandwick Worldwide

RELATED STORIES:
Coffee and sodas not tied to colon cancer   Omega-3 Fatty Acids May Reduce Risk of Colon Cancer   New function for colon cancer gene found   Virtual colonoscopy an effective colorectal cancer screening exam in Medicare age patientsComputed t   Hydrophobic proteins: Potential biomarkers for colorectal cancer   Colon Cancer Linked to Lineage   Colorectal Cancer Screening Rates Still Too Low   Smoking can double risk of colorectal polyps   Regular, long-term aspirin use reduces risk of colorectal cancer   Colonoscopy deemed best for colon cancer check   Omega 3s may help cut colon cancer risk   Patients not receiving follow-up tests after positive screening for colon cancer   Study Links Vitamin D to Colon Cancer Survival   Diabetes & hyper-insulinemia as predictors of colorectal cancer risk   Lack of sleep linked to risky colon polyps   Identified a cause of resistance to colon cancer treatment   Virtual colonoscopy is an accurate screening method for colorectal cancer   Can a Cholesterol Drug Prevent Colon Cancer?   Gallstones a risk factor for colon tumors   Drug improves survival of colorectal cancer patients, trial results show   Genetic Differences Point to Ethnic and Racial Disparities in Colorectal Cancer Risk   March is National Colorectal Cancer Awareness Month

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]